Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

ESR, DAS28 may impact RA trajectory during biologic or targeted therapy

medwireNews, 27 Oct 2022

27-10-2022 | Rheumatology | News | Article medwireNews: Baseline erythrocyte sedimentation rate (ESR) and DAS28 may be the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.